14 Nov 2026, 07:28 PM

Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%

@newsfx

Sunharbo (asundexian) is the first FDA-approved factor XIa inhibitor for secondary stroke prevention, but key limitations and risks do remain.

Source Credit: foxnews.com